- Home
- ADCT vs EFT Comparison
ADCT vs EFT Comparison
Compare ADCT & EFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- EFT
- Stock Information
- Founded
- ADCT 2011
- EFT 2004
- Country
- ADCT Switzerland
- EFT United States
- Employees
- ADCT N/A
- EFT N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- EFT Finance Companies
- Sector
- ADCT Health Care
- EFT Finance
- Exchange
- ADCT Nasdaq
- EFT Nasdaq
- Market Cap
- ADCT 380.2M
- EFT 306.2M
- IPO Year
- ADCT 2020
- EFT N/A
- Fundamental
- Price
- ADCT $4.46
- EFT $11.49
- Analyst Decision
- ADCT Strong Buy
- EFT
- Analyst Count
- ADCT 6
- EFT 0
- Target Price
- ADCT $7.60
- EFT N/A
- AVG Volume (30 Days)
- ADCT 984.4K
- EFT 100.8K
- Earning Date
- ADCT 11-07-2025
- EFT 01-01-0001
- Dividend Yield
- ADCT N/A
- EFT 10.63%
- EPS Growth
- ADCT N/A
- EFT N/A
- EPS
- ADCT N/A
- EFT 1.73
- Revenue
- ADCT $77,246,000.00
- EFT N/A
- Revenue This Year
- ADCT $11.78
- EFT N/A
- Revenue Next Year
- ADCT $4.83
- EFT N/A
- P/E Ratio
- ADCT N/A
- EFT $7.62
- Revenue Growth
- ADCT 15.73
- EFT N/A
- 52 Week Low
- ADCT $1.05
- EFT $11.10
- 52 Week High
- ADCT $4.80
- EFT $13.44
- Technical
- Relative Strength Index (RSI)
- ADCT 59.09
- EFT 32.09
- Support Level
- ADCT $3.92
- EFT $11.46
- Resistance Level
- ADCT $4.80
- EFT $11.58
- Average True Range (ATR)
- ADCT 0.25
- EFT 0.10
- MACD
- ADCT 0.00
- EFT 0.01
- Stochastic Oscillator
- ADCT 61.36
- EFT 14.29
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About EFT Eaton Vance Floating Rate Income Trust of Beneficial Interest
Eaton Vance Floating-rate Income Trust is a closed-end management investment company. The company's objective is to provide a high level of current income and its secondary objective is capital appreciation.